HealthLeaders Media January 11, 2023
John Commins

Lowering the cost of prescription drugs is a key component of the Inflation Reduction Act.

KEY TAKEAWAYS

– CMS will publish the first 10 high-cost Medicare Part D drugs picked for negotiations on Sept. 1.

– The “negotiated maximum fair prices” for the drugs to be announced on Sept. 1, 2024, and the prices will take effect on Jan. 1, 2026.

– CMS will pick another 15 Part D drugs for 2027, 15 more Part B or Part D drugs for 2028, and 20 more Part B or Part D drugs for each year after that.

The federal government on Wednesday made public its timetable for the first round of its ballyhooed Medicare Drug Price Negotiation Program.

In a conference...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, CMS, Govt Agencies, HHS, Insurance, Medicare, Pharma, Pharma / Biotech
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Prior authorizations, pharmacy transparency, vertical integration all part of the Medicare 2026 rule
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
New Proposal Aims to Expand Medicaid and Medicare Coverage for Obesity Drugs

Share This Article